Three-Parent Embryos: Medical World Falls Out Over Eggs, Cells and Terminology
By Steve Connor,
The Independent
| 02. 08. 2015
Untitled Document
It may seem strange that an expert in cloning – the man who produced the first clones of an adult monkey – is now dabbling in a technique that has become widely known as “mitochondrial donation”, a term with the more vulgar moniker of “three-parent” embryos.
Shoukhrat Mitalipov has earned a global reputation as a superb experimentalist able to perform procedures on eggs and embryos that have defied many of his peers. Born in the Soviet Union, in what is now Kazakhstan, and trained in Moscow, Dr Mitalipov, 53, emigrated to the United States in the mid-1990s. Since then he has created shock-waves around the world with his prowess in the manipulation of eggs and embryos.
He now intends to use mitochondrial donation as a treatment for age-related infertility, providing he receives approval for clinical trials.
For many this is confusing, and the reason has much to do with how the scientific terminology surrounding this technique has been subtly manipulated over recent years to make it more publicly acceptable.
Mitochondrial donation is also known as mitochondrial transfer, and...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
